Beyond the Elevator Pitch | Inside Start-up Stories | Part 6
What if we could make cutting-edge cell therapies accessible to all, regardless of financial status? π
CYTEA BIO is turning this vision into reality.
As HeadhunterAngels, we celebrate innovative biotech startups that are making a difference. Today, we’re excited to introduce CYTEA BIO, a Swiss-French biotech company based in Montpellier:
CYTEA BIO is addressing the urgent need for affordable and scalable cell therapies. Their groundbreaking ππ’π§β’ ππ₯ππππ¨π«π¦ enables the production of powerful antibody-cell conjugates, revolutionizing treatments for cancers and immune diseases.
Key innovations include:
𧬠Modular ππ’π§β’ ππ₯ππππ¨π«π¦: creating flexible, powerful treatments for oncology and immunology.
π§ͺ Affordable solutions: reducing the costs of cell therapies, making them more accessible.
π High-efficacy treatments: enhancing patient outcomes with minimal side effects.
π Global impact: offering hope to patients worldwide, irrespective of wealth.
π Read the full interview with COO Marc CRITON and learn more about how CYTEA BIO is transforming the future of cell therapy!
